In a regulatory filing, Procter & Gamble Health Care CEO Jennifer Davis disclosed the sale of 4,447 common shares of the company on October 2 at a price of $171.6541 per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Stellantis cuts 2024 targets, TPG acquires AT&T’s DirecTV stake: Morning Buzz
- Disney upgraded, JPMorgan downgraded: Wall Street’s top analyst calls
- Barclays downgrades Procter & Gamble on exposure to slowing markets
- Procter & Gamble downgraded to Equal Weight from Overweight at Barclays
- Procter & Gamble initiated with a Neutral at Piper Sandler